Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Key Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (82)
Cancellation by sponsor (66)

Date

2024 (6)
2023 (11)
2022 (7)
2021 (6)
2020 (5)
2019 (6)
2018 (11)
2017 (7)
2016 (2)
2015 (40)
2014 (4)
2012 (4)
2011 (2)
2010 (2)
2009 (6)
2008 (3)
2007 (1)
2006 (3)
2005 (1)
2004 (2)
2003 (1)
2001 (2)
1999 (1)
1995 (1)
1994 (2)
1993 (1)
1992 (3)
1991 (8)

Results for "[search-keyword]"

Search

Sponsor content

148 result(s) found, displaying 101 to 110

Key Pharmaceuticals Pty Ltd -OvuPlan Scope - In-Vitro Diagnostics, Non-Sterile Cancelled under Section 41GL(d) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
KEY PHARMACEUTICALS DIAGNOSTIC GOODS, IN VITRO - HOME USE/PBS NON-STERILE 'PREGNOSIS CLEAR' Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
KEY PHARMACEUTICALS DIAGNOSTIC GOODS, IN VITRO - H OME USE/PBS 'OVUPLAN' NON-STERILE Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
STOMEX 20mg STRENGTH hyoscine butylbromide film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
HAMILTON SKIN ACTIVE DIMETHICREAM cream tube Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
HAMILTON DRY SKIN TREATMENT WASH lotion bottle Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
After Work Cream Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
HAMILTON FORMICARE SKIN GEL Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
KEY PHARMACEUTICALS DIAGNOSTIC GOODS, IN VITRO - HOME USE/PHARMACEUTICAL BENEFITS SCHEME "PREGNOSIS" Cancelled under Section 30(1)(c) of the Act

30 June 2015

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
OsteVit-D Vitamin D3 Liquid (192210)

18 November 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OsteVit-D Vitamin D3 Liquid.

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.